1. Home
  2. WGS vs CLM Comparison

WGS vs CLM Comparison

Compare WGS & CLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WGS
  • CLM
  • Stock Information
  • Founded
  • WGS 2017
  • CLM 1987
  • Country
  • WGS United States
  • CLM United States
  • Employees
  • WGS N/A
  • CLM N/A
  • Industry
  • WGS Retail: Computer Software & Peripheral Equipment
  • CLM Finance/Investors Services
  • Sector
  • WGS Technology
  • CLM Finance
  • Exchange
  • WGS Nasdaq
  • CLM Nasdaq
  • Market Cap
  • WGS 2.4B
  • CLM 2.3B
  • IPO Year
  • WGS N/A
  • CLM N/A
  • Fundamental
  • Price
  • WGS $122.04
  • CLM $8.18
  • Analyst Decision
  • WGS Strong Buy
  • CLM
  • Analyst Count
  • WGS 7
  • CLM 0
  • Target Price
  • WGS $102.14
  • CLM N/A
  • AVG Volume (30 Days)
  • WGS 579.2K
  • CLM 1.4M
  • Earning Date
  • WGS 10-28-2025
  • CLM 01-01-0001
  • Dividend Yield
  • WGS N/A
  • CLM 18.74%
  • EPS Growth
  • WGS N/A
  • CLM N/A
  • EPS
  • WGS 0.05
  • CLM N/A
  • Revenue
  • WGS $362,321,000.00
  • CLM N/A
  • Revenue This Year
  • WGS $35.84
  • CLM N/A
  • Revenue Next Year
  • WGS $18.46
  • CLM N/A
  • P/E Ratio
  • WGS $2,541.32
  • CLM N/A
  • Revenue Growth
  • WGS 48.70
  • CLM N/A
  • 52 Week Low
  • WGS $35.88
  • CLM $6.25
  • 52 Week High
  • WGS $136.00
  • CLM $8.84
  • Technical
  • Relative Strength Index (RSI)
  • WGS 52.27
  • CLM 52.36
  • Support Level
  • WGS $120.55
  • CLM $8.04
  • Resistance Level
  • WGS $129.25
  • CLM $8.31
  • Average True Range (ATR)
  • WGS 5.28
  • CLM 0.06
  • MACD
  • WGS -2.01
  • CLM 0.01
  • Stochastic Oscillator
  • WGS 9.64
  • CLM 50.00

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.

About CLM Cornerstone Strategic Value Fund Inc. New

Cornerstone Strategic Value Fund Inc is a closed-end management investment company. The fund's objective is to seek long-term capital appreciation through investments in equity securities of U.S. and non-U.S. companies. It invests in various sectors, which include financials, information technology, healthcare, consumer discretionary, industrials, utilities, energy, telecommunication services, materials, and other sectors.

Share on Social Networks: